Kyle Rose
Stock Analyst at Canaccord Genuity
(2.66)
# 1,965
Out of 5,097 analysts
115
Total ratings
53.76%
Success rate
13.43%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $432 → $450 | $291.57 | +54.34% | 17 | Dec 17, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $27 | $33.12 | -18.48% | 6 | Feb 26, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $356.52 | +22.01% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $89.36 | -20.55% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $27.20 | +161.03% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.43 | +52.46% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.51 | +562.25% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $20.70 | +6.28% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $67.43 | +122.45% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $2.18 | +12,285.32% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $20.81 | +29.75% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.14 | +1,215.79% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $32.74 | -54.18% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $161.45 | -24.43% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $6.07 | -34.10% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.48 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $89.80 | +39.20% | 7 | Feb 8, 2022 |
Insulet
Dec 17, 2025
Maintains: Buy
Price Target: $432 → $450
Current: $291.57
Upside: +54.34%
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $33.12
Upside: -18.48%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $356.52
Upside: +22.01%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $89.36
Upside: -20.55%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $27.20
Upside: +161.03%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.43
Upside: +52.46%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.51
Upside: +562.25%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $20.70
Upside: +6.28%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $67.43
Upside: +122.45%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $2.18
Upside: +12,285.32%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $20.81
Upside: +29.75%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.14
Upside: +1,215.79%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $32.74
Upside: -54.18%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $161.45
Upside: -24.43%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $6.07
Upside: -34.10%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $7.48
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $89.80
Upside: +39.20%